<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209972</url>
  </required_header>
  <id_info>
    <org_study_id>NL67905.091.18</org_study_id>
    <nct_id>NCT04209972</nct_id>
  </id_info>
  <brief_title>The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules</brief_title>
  <acronym>Coffee Break</acronym>
  <official_title>The Benefit of Ultra-high Resolution Computed Tomography: Precision of Repeated Volume Measurements of Pulmonary Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the variability of semi-automated volume measurements of pulmonary nodules on
      same-day repeated scans of equal radiation dose from two different CT scanners: One high-end
      CT scanner with standard spatial resolution (CT1) and one UHRCT scanner (CT2), in patients
      with known or suspected pulmonary metastases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Ultra-high resolution computed tomography (UHRCT) produces radiological images
      with a spatial resolution of 0.25 mm in a matrix of 1024x1024. This should decrease
      measurement variation of nodule growth as a marker of malignancy, by making nodule
      delineation more precise for automatic volumetry segmentation and volume doubling time
      assessment than in conventional CT. If possible, this can shorten follow up of incidental
      pulmonary nodules to exclude malignancy, with less medicalisation and patient anxiety.

      Objective: To assess the variability of semi-automated volume measurements of pulmonary
      nodules in patients with known or suspected pulmonary metastases on same-day repeated scans
      of equal radiation dose from two different CT scanners: CT scanner with standard spatial
      resolution (conventional CT, CT1) and UHRCT (CT2).

      Study design: This is a single center prospective trial on 80 patients with known or
      suspected pulmonary metastases who are scheduled for chest and/or abdominal CT. Study
      participants will undergo two additional partial chest CT scans on either CT 1 or CT 2 for
      research purpose only, at similar radiation dose. Patients are equally divided across CT 1
      and 2.

      Study population: Patients who are 18 years or older with known solid pulmonary nodules
      compatible with metastases and who are willing and able to give informed consent are
      eligible. Patients are excluded if they have less than two eligible pulmonary nodules with a
      z range of 16 cm. Nodules with calcifications, surrounding opacities, or vessel- or pleural
      abutment will be excluded from analysis.

      Main study parameters/endpoints: The main endpoint of this study is the upper limit of the
      95% confidence interval of repeated semi-automated nodule volume measurements of both CT
      scanners.

      Nature and extent of the burden and risks associated with participation, benefit and group
      relatedness:

      CT imaging is associated with risks related to the use of ionizing radiation. The CT protocol
      including the scheduled CT scan and the additional scans in this study has been carefully
      designed to have a total radiation dose at the same level as the achievable diagnostic
      reference level of chest CT in the Netherlands, which is 542 mGycm in 2013 (1). The burden
      associated with the two extra study CT acquisitions comprises a dose length product (DLP) of
      120.4 mGyâ€¢cm for research (1.7 mSv, which is lower than the background radiation of one year
      in the Netherlands, with a conversion factor of 0.014 from Deak et al (2)).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 11, 2019</start_date>
  <completion_date type="Actual">July 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups, 40 patients on one CT scanner, 40 different patients on the other CT scanner.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients does not know if he is on the standard CT scanner, or on the UHR CT scanner</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The main endpoint of this study is the difference in precision in millimeter between the two CT scanners.</measure>
    <time_frame>4 months</time_frame>
    <description>The precision of each scanner is obtained by the standard deviation between the two measurements. The difference between scanners is tested with an F-test and the precision of each scanner is shown by a Bland-Altman plot</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of image quality (segmentation errors)</measure>
    <time_frame>5 months</time_frame>
    <description>Evaluate the image quality of the scans</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of image quality (motion artefacts)</measure>
    <time_frame>5 months</time_frame>
    <description>Evaluate the image quality of the scans</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient characteristics (age)</measure>
    <time_frame>4 months</time_frame>
    <description>Patient characteristics (age)</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient characteristics (height)</measure>
    <time_frame>4 months</time_frame>
    <description>Patient characteristics (height)</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient characteristics (weight)</measure>
    <time_frame>4 months</time_frame>
    <description>Patient characteristics (weight)</description>
  </other_outcome>
  <other_outcome>
    <measure>Radiation dose</measure>
    <time_frame>4 months</time_frame>
    <description>Radiation dose</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Pulmonary Nodule, Solitary</condition>
  <arm_group>
    <arm_group_label>Patients on CT1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo two pre-contrast scans, and will be in between the two scans be off and on the table at a standard CT scanner. (Aquilion One Genesis, Canon Medical Systems)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients on CT2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo two pre-contrast scans, and will be in between the two scans be off and on the table at a UHRCT scanner. (Aquilion One Precision, Canon Medical Systems)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Ultra-High-Resolution CT scanner</intervention_name>
    <description>Patients will be divided on one of the two CT scanners. This group will be scanned on the Precision CT scanner.</description>
    <arm_group_label>Patients on CT2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Genesis high-end CT scanner</intervention_name>
    <description>Patients will be divided on one of the two CT scanners. This group will be scanned on the Aquilion one Genesis.</description>
    <arm_group_label>Patients on CT1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  A solid primary tumour anywhere in the body and solid, noncalcified nodules in the
             pulmonary parenchyma on previous CT scans suspected for pulmonary metastases,
             according to radiological reports

          -  Two lung nodules that do not abut vessels or pleura with a two dimensional diameter
             between 5 and 10 mm within a distance of each other of 16 cm in the craniocaudal
             direction

        Exclusion Criteria:

          -  Immobility (not able to stand up and get off the scanner table)

          -  Patients who received local pulmonary treatment: Radiotherapy, Excision, Ablation

          -  Patients with radiologically suspected lymphangitis carcinomatosa or consolidations
             around the nodules.

          -  Patients who only have calcified pulmonary nodules or nodules that abut vessels or
             pleura.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monique Brink, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>van der Molen AJ, Schilham A, Stoop P, Prokop M, Geleijns J. A national survey on radiation dose in CT in The Netherlands. Insights Imaging. 2013 Jun;4(3):383-90. doi: 10.1007/s13244-013-0253-9. Epub 2013 May 15.</citation>
    <PMID>23673455</PMID>
  </results_reference>
  <results_reference>
    <citation>Deak PD, Smal Y, Kalender WA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology. 2010 Oct;257(1):158-66. doi: 10.1148/radiol.10100047.</citation>
    <PMID>20851940</PMID>
  </results_reference>
  <results_reference>
    <citation>Alpert JB, Ko JP. Management of Incidental Lung Nodules: Current Strategy and Rationale. Radiol Clin North Am. 2018 May;56(3):339-351. doi: 10.1016/j.rcl.2018.01.002. Epub 2018 Mar 7. Review.</citation>
    <PMID>29622070</PMID>
  </results_reference>
  <results_reference>
    <citation>MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, Rubin GD, Schaefer-Prokop CM, Travis WD, Van Schil PE, Bankier AA. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017 Jul;284(1):228-243. doi: 10.1148/radiol.2017161659. Epub 2017 Feb 23.</citation>
    <PMID>28240562</PMID>
  </results_reference>
  <results_reference>
    <citation>Baldwin DR, Callister ME; Guideline Development Group. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax. 2015 Aug;70(8):794-8. doi: 10.1136/thoraxjnl-2015-207221. Epub 2015 Jul 1. Review.</citation>
    <PMID>26135833</PMID>
  </results_reference>
  <results_reference>
    <citation>Devaraj A, van Ginneken B, Nair A, Baldwin D. Use of Volumetry for Lung Nodule Management: Theory and Practice. Radiology. 2017 Sep;284(3):630-644. doi: 10.1148/radiol.2017151022. Review.</citation>
    <PMID>28825886</PMID>
  </results_reference>
  <results_reference>
    <citation>Wormanns D, Kohl G, Klotz E, Marheine A, Beyer F, Heindel W, Diederich S. Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol. 2004 Jan;14(1):86-92. Epub 2003 Nov 13.</citation>
    <PMID>14615902</PMID>
  </results_reference>
  <results_reference>
    <citation>Gietema HA, Schaefer-Prokop CM, Mali WP, Groenewegen G, Prokop M. Pulmonary nodules: Interscan variability of semiautomated volume measurements with multisection CT-- influence of inspiration level, nodule size, and segmentation performance. Radiology. 2007 Dec;245(3):888-94. Epub 2007 Oct 8.</citation>
    <PMID>17923508</PMID>
  </results_reference>
  <results_reference>
    <citation>Goodman LR, Gulsun M, Washington L, Nagy PG, Piacsek KL. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. AJR Am J Roentgenol. 2006 Apr;186(4):989-94.</citation>
    <PMID>16554568</PMID>
  </results_reference>
  <results_reference>
    <citation>Hein PA, Romano VC, Rogalla P, Klessen C, Lembcke A, Bornemann L, Dicken V, Hamm B, Bauknecht HC. Variability of semiautomated lung nodule volumetry on ultralow-dose CT: comparison with nodule volumetry on standard-dose CT. J Digit Imaging. 2010 Feb;23(1):8-17. doi: 10.1007/s10278-008-9157-5. Epub 2008 Sep 5.</citation>
    <PMID>18773240</PMID>
  </results_reference>
  <results_reference>
    <citation>Han D, Heuvelmans MA, Oudkerk M. Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening. Transl Lung Cancer Res. 2017 Feb;6(1):52-61. doi: 10.21037/tlcr.2017.01.05. Review.</citation>
    <PMID>28331824</PMID>
  </results_reference>
  <results_reference>
    <citation>Tanaka R, Yoshioka K, Takagi H, Schuijf JD, Arakita K. Novel developments in non-invasive imaging of peripheral arterial disease with CT: experience with state-of-the-art, ultra-high-resolution CT and subtraction imaging. Clin Radiol. 2019 Jan;74(1):51-58. doi: 10.1016/j.crad.2018.03.002. Epub 2018 Apr 5. Review.</citation>
    <PMID>29627067</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhou W, Montoya J, Gutjahr R, Ferrero A, Halaweish A, Kappler S, McCollough C, Leng S. Lung Nodule Volume Quantification and Shape Differentiation with an Ultra-High Resolution Technique on a Photon Counting Detector CT System. Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10132. pii: 101323Q. doi: 10.1117/12.2255736. Epub 2017 Mar 9.</citation>
    <PMID>28392613</PMID>
  </results_reference>
  <results_reference>
    <citation>de Hoop B, Gietema H, van Ginneken B, Zanen P, Groenewegen G, Prokop M. A comparison of six software packages for evaluation of solid lung nodules using semi-automated volumetry: what is the minimum increase in size to detect growth in repeated CT examinations. Eur Radiol. 2009 Apr;19(4):800-8. doi: 10.1007/s00330-008-1229-x. Epub 2008 Nov 19.</citation>
    <PMID>19018537</PMID>
  </results_reference>
  <results_reference>
    <citation>Leng S, Gutjahr R, Ferrero A, Kappler S, Henning A, Halaweish A, Zhou W, Montoya J, McCollough C. Ultra-High Spatial Resolution, Multi-Energy CT using Photon Counting Detector Technology. Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10132. pii: 101320Y. doi: 10.1117/12.2255589. Epub 2017 Mar 9.</citation>
    <PMID>28392615</PMID>
  </results_reference>
  <results_reference>
    <citation>Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.</citation>
    <PMID>2868172</PMID>
  </results_reference>
  <results_reference>
    <citation>Kalra MK, Sodickson AD, Mayo-Smith WW. CT Radiation: Key Concepts for Gentle and Wise Use. Radiographics. 2015 Oct;35(6):1706-21. doi: 10.1148/rg.2015150118.</citation>
    <PMID>26466180</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>December 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2019</study_first_posted>
  <last_update_submitted>December 23, 2019</last_update_submitted>
  <last_update_submitted_qc>December 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultra-high resolution CT</keyword>
  <keyword>volume measumerents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
    <mesh_term>Solitary Pulmonary Nodule</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Not decided yet</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

